» Articles » PMID: 35326259

Stroke Genomics: Current Knowledge, Clinical Applications and Future Possibilities

Overview
Journal Brain Sci
Publisher MDPI
Date 2022 Mar 25
PMID 35326259
Authors
Affiliations
Soon will be listed here.
Abstract

The pathophysiology of stoke involves many complex pathways and risk factors. Though there are several ongoing studies on stroke, treatment options are limited, and the prevalence of stroke is continuing to increase. Understanding the genomic variants and biological pathways associated with stroke could offer novel therapeutic alternatives in terms of drug targets and receptor modulations for newer treatment methods. It is challenging to identify individual causative mutations in a single gene because many alleles are responsible for minor effects. Therefore, multiple factorial analyses using single nucleotide polymorphisms (SNPs) could be used to gain new insight by identifying potential genetic risk factors. There are many studies, such as Genome-Wide Association Studies (GWAS) and Phenome-Wide Association Studies (PheWAS) which have identified numerous independent loci associated with stroke, which could be instrumental in developing newer drug targets and novel therapies. Additionally, using analytical techniques, such as meta-analysis and Mendelian randomization could help in evaluating stroke risk factors and determining treatment priorities. Combining SNPs into polygenic risk scores and lifestyle risk factors could detect stroke risk at a very young age and help in administering preventive interventions.

Citing Articles

Multidimensional Approach of Genotype and Phenotype in Stroke Etiology: The MAGPIE Study.

Ranjan R, Adhikary D, Barman S, Islam M, Ken-Dror G, Yusuf M Health Sci Rep. 2024; 7(12):e70227.

PMID: 39633841 PMC: 11615695. DOI: 10.1002/hsr2.70227.


Systems-level computational modeling in ischemic stroke: from cells to patients.

Li G, Zhao Y, Ma W, Gao Y, Zhao C Front Physiol. 2024; 15:1394740.

PMID: 39015225 PMC: 11250596. DOI: 10.3389/fphys.2024.1394740.


Polymorphism of , the gene encoding a heat-resistant obscure (Hero) protein with chaperone activity, is a novel link in ischemic stroke.

Belykh A, Soldatov V, Stetskaya T, Kobzeva K, Soldatova M, Polonikov A IBRO Neurosci Rep. 2023; 14:453-461.

PMID: 37252629 PMC: 10209486. DOI: 10.1016/j.ibneur.2023.05.004.


Association of C-reactive protein gene polymorphisms with the risk of ischemic stroke: A systematic review and meta-analysis.

Chen W, Zhu X, Hu Y, Hong H, Kuang L, Liang N Brain Behav. 2023; 13(6):e2976.

PMID: 37221147 PMC: 10275524. DOI: 10.1002/brb3.2976.

References
1.
Matarin M, Brown W, Scholz S, Simon-Sanchez J, Fung H, Hernandez D . A genome-wide genotyping study in patients with ischaemic stroke: initial analysis and data release. Lancet Neurol. 2007; 6(5):414-20. PMC: 2613843. DOI: 10.1016/S1474-4422(07)70081-9. View

2.
Bugiani M, Kevelam S, Bakels H, Waisfisz Q, Ceuterick-de Groote C, Niessen H . Cathepsin A-related arteriopathy with strokes and leukoencephalopathy (CARASAL). Neurology. 2016; 87(17):1777-1786. DOI: 10.1212/WNL.0000000000003251. View

3.
Rufa A, Guideri F, Acampa M, Cevenini G, Bianchi S, De Stefano N . Cardiac autonomic nervous system and risk of arrhythmias in cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL). Stroke. 2007; 38(2):276-80. DOI: 10.1161/01.STR.0000254530.38417.07. View

4.
Li Z, Li J, Tang N . Long noncoding RNA Malat1 is a potent autophagy inducer protecting brain microvascular endothelial cells against oxygen-glucose deprivation/reoxygenation-induced injury by sponging miR-26b and upregulating ULK2 expression. Neuroscience. 2017; 354:1-10. DOI: 10.1016/j.neuroscience.2017.04.017. View

5.
Ye Z, Zhang H, Sun L, Cai H, Hao Y, Xu Z . GWAS-Supported CRP Gene Polymorphisms and Functional Outcome of Large Artery Atherosclerotic Stroke in Han Chinese. Neuromolecular Med. 2018; 20(2):225-232. DOI: 10.1007/s12017-018-8485-y. View